| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 39.6865 | 6 |
| GSM780708 | Untreated after 4 days (C2_1) | 41.9107 | 13 |
| GSM780709 | Untreated after 4 days (C3_1) | 45.6473 | 30 |
| GSM780719 | Untreated after 4 days (C1_2) | 47.832 | 40 |
| GSM780720 | Untreated after 4 days (C2_2) | 45.3937 | 29 |
| GSM780721 | Untreated after 4 days (C3_2) | 39.1935 | 5 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 51.1564 | 52 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 45.6979 | 31 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 43.8597 | 21 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 39.771 | 6 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 45.2565 | 28 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 41.6238 | 12 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 46.8355 | 36 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 46.3357 | 34 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 44.633 | 25 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 46.0526 | 32 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 44.2382 | 23 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 47.3651 | 38 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 41.8313 | 12 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 42.2801 | 14 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 38.659 | 4 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 41.3424 | 11 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 45.5118 | 30 |